Fwd: Peregrine initiates dosing in Phase II lung cancer trial (Pharmaceutical Business Review)

---------- Forwarded message ----------
From: Yahoo! News Search Results for lung cancer <rssfwd@rssfwd.com>
Date: Fri, Jul 4, 2008 at 3:26 AM
Subject: Peregrine initiates dosing in Phase II lung cancer trial (Pharmaceutical Business Review)
To: mesothelioma77@gmail.com


Peregrine Pharmaceuticals has initiated patient screening and dosing in a Phase II trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with non-small cell lung cancer.

Wed, 02 Jul 2008 00:46:15 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/lung+cancer/SIG=13c60qv4a/*http%3A//www.pharmaceutical-business-review.com/article_news.asp?guid=13036690-82A5-46D6-B3A9-E429F7312777
--
 Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc